Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling

Lyra O. Randzavola, Paige M. Mortimer, Emma Garside, Elizabeth R. Dufficy, Andrea Schejtman, Georgia Roumelioti, Lu Yu, Mercedes Pardo, Kerstin Spirohn, Charlotte Tolley, Cordelia Brandt, Katherine Harcourt, Esme Nichols, Mike Nahorski, Geoff Woods, James C. Williamson, Shreehari Suresh, John M. Sowerby, Misaki Matsumoto, Celio X.C. Santos, Cher Shen Kiar, Subhankar Mukhopadhyay, Will M. Rae, Gordon J. Dougan, John Grainger, Paul J. Lehner, Michael Calderwood, Jyoti Choudhary, Simon Clare, Anneliese Speak, Giorgia Santilli, Alex Bateman, Kenneth G. C. Smith, Francesca Magnani, David C. Thomas
doi: https://doi.org/10.1101/2021.09.14.460103
Lyra O. Randzavola
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, W12 0NN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paige M. Mortimer
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, W12 0NN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Garside
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, W12 0NN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth R. Dufficy
2The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0SP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Schejtman
3Molecular Immunology Unit, UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgia Roumelioti
4Functional Proteomics, Division of Cancer Biology, Institute of Cancer Research, London, SW7 3RP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Yu
4Functional Proteomics, Division of Cancer Biology, Institute of Cancer Research, London, SW7 3RP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mercedes Pardo
4Functional Proteomics, Division of Cancer Biology, Institute of Cancer Research, London, SW7 3RP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerstin Spirohn
5Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Tolley
6Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cordelia Brandt
6Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine Harcourt
6Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esme Nichols
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, W12 0NN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Nahorski
7Cambridge Institute of Medical Research, University of Cambridge, Cambridge, CB2 0XY, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoff Woods
7Cambridge Institute of Medical Research, University of Cambridge, Cambridge, CB2 0XY, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James C. Williamson
2The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0SP, United Kingdom
11Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, CB2 0AW, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shreehari Suresh
2The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0SP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John M. Sowerby
2The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0SP, United Kingdom
11Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, CB2 0AW, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Misaki Matsumoto
8Department of Pharmacology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celio X.C. Santos
9School of Cardiovascular Medicine and Sciences, James Black Centre, King’s College London, London, SE5 9NU, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cher Shen Kiar
6Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Subhankar Mukhopadhyay
6Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Will M. Rae
2The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0SP, United Kingdom
11Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, CB2 0AW, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon J. Dougan
2The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0SP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Grainger
10Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J. Lehner
2The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0SP, United Kingdom
11Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, CB2 0AW, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Calderwood
5Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jyoti Choudhary
4Functional Proteomics, Division of Cancer Biology, Institute of Cancer Research, London, SW7 3RP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Clare
6Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anneliese Speak
6Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giorgia Santilli
3Molecular Immunology Unit, UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Bateman
12European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, CB10 1SD, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth G. C. Smith
2The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0SP, United Kingdom
11Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, CB2 0AW, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Magnani
13Department of Biology and Biotechnology, University of Pavia, Pavia, 27100, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected] [email protected]
David C. Thomas
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, W12 0NN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected] [email protected]
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

EROS (Essential for Reactive Oxygen Species) protein is indispensable for expression of gp91phox, the catalytic core of the phagocyte NADPH oxidase. EROS deficiency in humans is a novel cause of the severe immunodeficiency, chronic granulomatous disease (CGD), but its mechanism of action was unknown until now. We elucidate the role of EROS, showing it acts at the earliest stages of gp91phox maturation. It binds the immature 58kDa gp91phox directly, preventing gp91phox degradation and allowing glycosylation via the oligosaccharyltransferase (OST) machinery and the incorporation of the heme prosthetic groups essential for catalysis. EROS also regulates the purine receptors P2X7 and P2X1 through direct interactions and P2X7 is almost absent in EROS deficient mouse and human primary cells. Accordingly, lack of EROS results in markedly abnormal P2X7 signalling, inflammasome activation and T cell responses. The loss of both ROS and P2X7 signalling leads to resistance to influenza infection. Our work identifies EROS as a highly selective chaperone for key proteins in innate and adaptive immunity and a rheostat for immunity to infection. It has profound implications for our understanding of immune physiology, ROS dysregulation and possibly gene therapy.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • Authors added; Discussion section updated to discuss the role of NOX2-derived reactive oxygen species and P2X7 deficiency in the protection against influenza virus infection; Figure 2 revised; Figure 3 revised; Figure 5 revised; Figure 6 revised; Supplemental files updated.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 04, 2022.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling
Lyra O. Randzavola, Paige M. Mortimer, Emma Garside, Elizabeth R. Dufficy, Andrea Schejtman, Georgia Roumelioti, Lu Yu, Mercedes Pardo, Kerstin Spirohn, Charlotte Tolley, Cordelia Brandt, Katherine Harcourt, Esme Nichols, Mike Nahorski, Geoff Woods, James C. Williamson, Shreehari Suresh, John M. Sowerby, Misaki Matsumoto, Celio X.C. Santos, Cher Shen Kiar, Subhankar Mukhopadhyay, Will M. Rae, Gordon J. Dougan, John Grainger, Paul J. Lehner, Michael Calderwood, Jyoti Choudhary, Simon Clare, Anneliese Speak, Giorgia Santilli, Alex Bateman, Kenneth G. C. Smith, Francesca Magnani, David C. Thomas
bioRxiv 2021.09.14.460103; doi: https://doi.org/10.1101/2021.09.14.460103
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling
Lyra O. Randzavola, Paige M. Mortimer, Emma Garside, Elizabeth R. Dufficy, Andrea Schejtman, Georgia Roumelioti, Lu Yu, Mercedes Pardo, Kerstin Spirohn, Charlotte Tolley, Cordelia Brandt, Katherine Harcourt, Esme Nichols, Mike Nahorski, Geoff Woods, James C. Williamson, Shreehari Suresh, John M. Sowerby, Misaki Matsumoto, Celio X.C. Santos, Cher Shen Kiar, Subhankar Mukhopadhyay, Will M. Rae, Gordon J. Dougan, John Grainger, Paul J. Lehner, Michael Calderwood, Jyoti Choudhary, Simon Clare, Anneliese Speak, Giorgia Santilli, Alex Bateman, Kenneth G. C. Smith, Francesca Magnani, David C. Thomas
bioRxiv 2021.09.14.460103; doi: https://doi.org/10.1101/2021.09.14.460103

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Immunology
Subject Areas
All Articles
  • Animal Behavior and Cognition (6101)
  • Biochemistry (13883)
  • Bioengineering (10580)
  • Bioinformatics (33623)
  • Biophysics (17327)
  • Cancer Biology (14392)
  • Cell Biology (20386)
  • Clinical Trials (138)
  • Developmental Biology (10994)
  • Ecology (16223)
  • Epidemiology (2067)
  • Evolutionary Biology (20531)
  • Genetics (13527)
  • Genomics (18822)
  • Immunology (13949)
  • Microbiology (32538)
  • Molecular Biology (13547)
  • Neuroscience (70958)
  • Paleontology (533)
  • Pathology (2222)
  • Pharmacology and Toxicology (3781)
  • Physiology (5961)
  • Plant Biology (12170)
  • Scientific Communication and Education (1826)
  • Synthetic Biology (3406)
  • Systems Biology (8246)
  • Zoology (1875)